Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Private placement brings in SEK70mm for OxThera

Executive Summary

OxThera AB (developing hyperoxaluria treatments) raised SEK70mm ($10.6mm) in a financing led by Kurma Partners (via its Kurma Biofund II), which was joined by other new investors IdInvest Partners and Mayo Clinic, and undisclosed returning shareholders. The company’s lead candidate Oxabact is in Phase II.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies